1-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazole → HCID 71765298, compound
Reaction equation
[CH3:1][N:2]1[C:6]2[CH:7]=[CH:8][C:9](B3OC(C)(C)C(C)(C)O3)=[CH:10][C:5]=2[N:4]=[CH:3]1.[NH2:20][C:21]1[C:30]2[C:25](=[C:26](Br)[CH:27]=[CH:28][CH:29]=2)[N:24]=[N:23][C:22]=1[C:32]([NH2:34])=[O:33]>C(O)=O>[NH2:20][C:21]1[C:30]2[C:25](=[C:26]([C:9]3[CH:8]=[CH:7][C:6]4[N:2]([CH3:1])[CH:3]=[N:4][C:5]=4[CH:10]=3)[CH:27]=[CH:28][CH:29]=2)[N:24]=[N:23][C:22]=1[C:32]([NH2:34])=[O:33]Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
A formic acid salt of the title compound was prepared in a manner similar to EXAMPLE 1 using 1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]imidazole and 4-amino-8-bromocinnoline-3-carboxamide. 1H NMR (500 MHz, CD3OD) δ ppm 3.91 (s, 3 H), 8.54 (s, 1 H), 8.64 (d, J=8 Hz 1 H), 8.73 (d, J=8 Hz 2 H), 8.84 (d, J=16 Hz 1 H), 9.29 (d, J=8 Hz 1 H), 9.99 (s, 1 H); ESI-MS m/z [M+H]+ 319.2.
Sources & evidence
- ORD record
- ord-56a6cecfecb1457682e8c0d6463f24f5
- Source dataset
- uspto-grants-2016_06
- Patent number
- US09365566B2
Reaction notes
Loading…